Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronidase is an enzyme that catalyzes the hydrolysis of hyaluronic acid in connective tissue, thereby increasing tissue permeability. When combined with rehydration fluids (such as normal saline or other subcutaneous infusions), it facilitates the absorption and dispersion of these fluids for the treatment of dehydration via hypodermoclysis (subcutaneous fluid administration). This combination is used to enhance the permeation and resorption of injected solutions and can also be used to increase absorption of other drugs administered subcutaneously. The mechanism involves enzymatic breakdown of intercellular barriers by depolymerizing hyaluronic acid[1][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronidase + rehydration fluid.